{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:28:16Z","timestamp":1785367696351,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.janxdis.2007.01.005","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T12:27:05Z","timestamp":1170678425000},"page":"88-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia"],"prefix":"10.1016","volume":"22","author":[{"given":"Christine","family":"Mrakotsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Masek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Raches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Hsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ray","family":"DeMaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gonzalez-Heydrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.janxdis.2007.01.005_bib1","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"17","key":"10.1016\/j.janxdis.2007.01.005_bib2","first-page":"54","article-title":"Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety","volume":"59","author":"Ballenger","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"17","key":"10.1016\/j.janxdis.2007.01.005_bib3","first-page":"27","article-title":"Social anxiety disorder: etiology and early clinical presentation","volume":"59","author":"Beidel","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2007.01.005_bib4","first-page":"8","article-title":"What are the adult consequences of childhood shyness?","volume":"15","author":"Beidel","year":"1998","journal-title":"Harvard Mental Health Letter"},{"key":"10.1016\/j.janxdis.2007.01.005_bib5","first-page":"643","article-title":"Psychopathology of childhood social phobia","volume":"38","author":"Beidel","year":"1999","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1016\/j.janxdis.2007.01.005_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.jcp.0000085408.08426.05","article-title":"Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study","volume":"23","author":"Behnke","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.janxdis.2007.01.005_bib7","series-title":"American College of Neuropsychopharmacology, 37th Annual Meeting","article-title":"Rapid onset of therapeutic action in major depression: a comparative trial of mirtazapine and paroxetine","author":"Benkert","year":"1998"},{"issue":"4","key":"10.1016\/j.janxdis.2007.01.005_bib8","first-page":"814","article-title":"A 3-year follow-up of children with and without behavioral inhibition","volume":"32","author":"Biederman","year":"1993","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2007.01.005_bib9","first-page":"519","article-title":"A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression","volume":"56","author":"Bremner","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.janxdis.2007.01.005_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11920-000-0080-9","article-title":"Recent developments in child and adolescent social phobia","volume":"2","author":"Chavira","year":"2000","journal-title":"Current Psychiatry Report"},{"issue":"5","key":"10.1016\/j.janxdis.2007.01.005_bib11","first-page":"564","article-title":"Sertraline in children and adolescents with social anxiety disorder: an open trial","volume":"40","author":"Compton","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.janxdis.2007.01.005_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0033291700025484","article-title":"The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study","volume":"23","author":"Davidson","year":"1993","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1016\/j.janxdis.2007.01.005_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1016\/j.janxdis.2007.01.005_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881105056527","article-title":"Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study","volume":"19","author":"Gambi","year":"2005","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.janxdis.2007.01.005_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3758\/BF03196706","article-title":"Likelihood ratios: a simple and flexible statistic for empirical psychologists","volume":"11","author":"Glover","year":"2004","journal-title":"Psychonomic Bulletin Review"},{"issue":"7","key":"10.1016\/j.janxdis.2007.01.005_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4088\/JCP.v60n0705","article-title":"Mirtazapine in major depression with comorbid generalized anxiety disorder","volume":"60","author":"Goodnick","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2007.01.005_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/1044546041649110","article-title":"Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study","volume":"14","author":"Haapasalo-Pesu","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.janxdis.2007.01.005_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1207\/s15374424jccp2703_2","article-title":"Predictors of severity of absenteeism in children with anxiety-based school refusal","volume":"27","author":"Hansen","year":"1998","journal-title":"Journal of Clinical Child Psychology"},{"key":"10.1016\/j.janxdis.2007.01.005_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-7610.1995.tb01300.x","article-title":"The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade","volume":"36","author":"Ialongo","year":"1995","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib20","series-title":"Children's Depression Inventory (CDI)","author":"Kovacs","year":"1992"},{"issue":"18","key":"10.1016\/j.janxdis.2007.01.005_bib21","first-page":"22","article-title":"Update on the diagnosis and treatment of social anxiety disorder","volume":"60","author":"Liebowitz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0006-3223(02)01867-X","article-title":"Assessing and interpreting treatment effects in longitudinal clinical trials with subject dropout","volume":"53","author":"Mallinckrodt","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib23","unstructured":"Masia, C.L., Klein, R.G., & Liebowitz, M.R. (1999). The Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA) (available from Carrie Masia-Warner, NYU Child Study Center, 215 Lexington Avenue, 13th floor, New York, NY 10016)."},{"key":"10.1016\/j.janxdis.2007.01.005_bib24","first-page":"1076","article-title":"The Liebowitz Social Anxiety Scale for Children: an initial psychometric investigation","volume":"42","author":"Masia-Warner","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1016\/j.janxdis.2007.01.005_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.jcp.0000186871.04984.8d","article-title":"Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study","volume":"25","author":"Muehlbacher","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.janxdis.2007.01.005_bib26","series-title":"Manual for the ECDEU assessment battery","article-title":"CGI: clinical global impressions","author":"National Institute of Mental Health (NIMH)","year":"1970"},{"key":"10.1016\/j.janxdis.2007.01.005_bib27","unstructured":"Organon. (2001). NDA 20-415 SE5-011 Drug: Mitrazapine (Remeron). Pediatric Supplement SE5-011. Retrieved May 7, 2001, from http:\/\/www.fda.gov\/cder\/foi\/esum\/2004\/20415SE5_011_Mirtazapine 20MO 20ReviewFIN.pdf."},{"issue":"10","key":"10.1016\/j.janxdis.2007.01.005_bib28","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4088\/JCP.v65n1015","article-title":"Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study","volume":"65","author":"Pallanti","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","article-title":"The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders","volume":"55","author":"Pine","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib30","series-title":"Diagnostic Interview for Children and Adolescents-IV (DICA-IV)","author":"Reich","year":"1997"},{"issue":"17","key":"10.1016\/j.janxdis.2007.01.005_bib31","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","author":"Research Unit on Pediatric Psychopharmacology Anxiety Study Group","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.janxdis.2007.01.005_bib32","series-title":"Revised Children's Manifest Anxiety Scale manual","year":"1985"},{"key":"10.1016\/j.janxdis.2007.01.005_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpsyc.1992.01820040034004","article-title":"Social phobia: comorbidity and morbidity in an epidemiologic sample","volume":"49","author":"Schneier","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib34","first-page":"322","article-title":"Functional impairment in social phobia","volume":"55","author":"Schneier","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2007.01.005_bib35","unstructured":"Schutte, A.-J., Vester, E., & Kremer, C. (1999). Tolerability of mirtazapine versus SSRIs [abstract]. WPA, Hamburg."},{"issue":"3","key":"10.1016\/j.janxdis.2007.01.005_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1520-6394(1998)7:3<134::AID-DA7>3.0.CO;2-B","article-title":"Medication treatments for panic disorder and social phobia","volume":"7","author":"Stein","year":"1998","journal-title":"Depression and Anxiety"},{"issue":"3","key":"10.1016\/j.janxdis.2007.01.005_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archpsyc.58.3.251","article-title":"Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults","volume":"58","author":"Stein","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2007.01.005_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1037\/0021-843X.101.2.326","article-title":"Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder","volume":"101","author":"Turner","year":"1992","journal-title":"Journal of Abnormal Psychology"},{"issue":"6","key":"10.1016\/j.janxdis.2007.01.005_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00004850-200211000-00008","article-title":"Mirtazapine in social anxiety disorder: a pilot study","volume":"17","author":"Van Veen","year":"2002","journal-title":"International Clinical Psychopharmacology"},{"issue":"11","key":"10.1016\/j.janxdis.2007.01.005_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","volume":"61","author":"Wagner","year":"2004","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1016\/j.janxdis.2007.01.005_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4088\/JCP.v59n0606","article-title":"Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group","volume":"59","author":"Wheatley","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2007.01.005_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0033291798008174","article-title":"Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity","volume":"29","author":"Wittchen","year":"1999","journal-title":"Psychological Medicine"},{"issue":"9","key":"10.1016\/j.janxdis.2007.01.005_bib43","first-page":"1086","article-title":"Life course outcomes of young people with anxiety disorders in adolescence","volume":"40","author":"Woodward","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618507000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618507000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:48:44Z","timestamp":1760136524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618507000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"alternative-id":["S0887618507000205"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2007.01.005","relation":{},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2007.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}